rosiglitazone has been researched along with varenicline in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Ledford, H | 1 |
| Kesselheim, AS; Sarpatwari, A; Yeh, JS | 1 |
1 review(s) available for rosiglitazone and varenicline
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
3 other study(ies) available for rosiglitazone and varenicline
| Article | Year |
|---|---|
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Drug safety crackdown revs up.
Topics: Benzazepines; Female; Humans; Male; Product Surveillance, Postmarketing; Quinoxalines; Risk Assessment; Rosiglitazone; Thiazolidinediones; United States; United States Food and Drug Administration; Varenicline; Violence | 2010 |
Ethical and Practical Considerations in Removing Black Box Warnings from Drug Labels.
Topics: Drug Approval; Drug Industry; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Legislation, Drug; Prescription Drugs; Rosiglitazone; Thiazolidinediones; United States; United States Food and Drug Administration; Varenicline | 2016 |